Drugs.com - Pharma News
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
3102 records returned
Saatchi & Saatchi Wellness Names Russell as Managing Director
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAATCHI & SAATCHI WELLNESS NAMES RUSSELL AS MANAGING
DIRECTOR
NEW YORK, NY, November 20, 2009-Saatchi & Saatchi Wellness
(SSW), a division of the Publicis Healthcare Communications Group,
announced today that Ned Russell has been named EVP,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
Antitrust Lawyer Files Suit to Stop Pfizer MergerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
[The Day, New
London, Conn.]
From Day, The (New London, CT) (November 20, 2009)
Nov. 20--A prominent San Francisco antitrust attorney said
Thursday he has filed a request in federal court for a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
The Botax? Nip/Tuck Levy to Help Health Care PlanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 20, 2009)
WASHINGTON--They call it the "Botax." The White House and Senate
Democrats have turned to a proposal to tax breast implants, tummy
tucks, wrinkle-smoothing injections and other procedures as they
search for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
Moody's Gives Negative View on Pharma CreditEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 19, 2009)
NEW YORK--Moody's Investors Service issued a negative opinion on
the pharmaceutical industry Thursday, saying drugmaker credit
ratings will be under pressure until early 2012 because they won't
be able to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
Retiring Lilly Research Exec Steven Paul Gets $2 Million in Severance [The Indianapolis Star]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Indianapolis Star (IN) (November 20, 2009)
Nov. 20--The top research executive at Eli Lilly and Co. will
receive a $2 million cash severance payment and be credited with
extra years of service when he retires in February -- a move... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
FDA Panel Backs Safety, Benefits of SpirivaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 19, 2009)
WASHINGTON-Federal health experts on Thursday brushed off
lingering safety questions about a popular inhaler drug and
suggested it carry bolder benefit claims.
The Food and Drug Administration's panel of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
WHO: Swine Flu Shot Not Causing DeathsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 19, 2009)
GENEVA--The World Health Organization on Thursday ruled out
swine flu vaccine as the cause of death in 41 people who had
received the flu shot.
WHO vaccines chief Marie-Paule Kieny said deaths... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
FDA Issues 22 Warning Letters to Web Site OperatorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Part of International Internet Week of Action
SILVER SPRING, Md., Nov. 19 /PRNewswire-USNewswire/ --The U.S.
Food and Drug Administration today completed a coordinated,
weeklong, international effort, called the International Internet
Week of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
PhRMA Statement on Misleading Reports About Price GrowthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Washington, November 18, 2009 — Pharmaceutical Research
and Manufacturers of America(PhRMA) Senior Vice President Ken
Johnson issued the following statement today:
“It’s pretty obvious that the calls to hold... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Time to Blow Up the Pharmaceutical Sales Model? New Deloitte DebateEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
What: "New Commercial Model: Science or Swag?"
Who: W. Scott Evangelista, principal, Deloitte Consulting LLP
When: Available immediately
Where: www.deloitte.com/us/debates/scienceorswag
NEW YORK, Nov. 19 /PRNewswire/ -- Details:... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Committee Leaders Call for GAO Analysis of Recent Prescription Drug Price IncreasesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WASHINGTON, Nov. 18, 2009--Leaders of the House Ways and Means
and Energy and Commerce Committees sent a letter to the Government
Accountability Office (GAO) last night requesting an expedited
report on recent trends in prescription drug... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
FDA Panel Backs Pfizer's Enhanced Vaccine for KidsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 19, 2009)
BETHESDA, Md.--Federal health experts said Wednesday an updated
version of Pfizer's best-selling anti-infection vaccine is safe and
effective for infants and toddlers, despite company studies that
failed to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
AstraZeneca Seeks Brilinta Approval in USEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 19, 2009)
LONDON–AstraZeneca PLC said Thursday it has applied to
U.S. regulators to market its blood clot preventer Brilinta, a
potential new big seller for the company.
AstraZeneca submitted a new drug... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Genentech, Biogen Get FDA Request on RituxanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 18, 2009)
NEW YORK--Genentech Inc. and partner Biogen Idec Inc. said
Wednesday the Food and Drug Administration is withholding a
decision to expand approval of Rituxan as a leukemia treatment,
pending further... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Ex-Pharma Executive Runs as Dem for Kansas GovernorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 18, 2009)
TOPEKA, Kan.--A former pharmaceutical company executive who
returned to Kansas this year announced Tuesday that he's running
for governor, giving Democrats a declared candidate.
Tom Wiggans, 57, appointed a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2009 Category: Pharmaceuticals Source Type: news
InterMune Shares Fall on Change in Hepatitis StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 17, 2009)
NEW YORK--Shares of InterMune Inc. fell Tuesday after the
biotechnology company said it would discontinue a high-dose of its
experimental Hepatitis C treatment in a study because of potential
liver... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2009 Category: Pharmaceuticals Source Type: news
Pfizer Enters Tropical Disease Drug PartnershipEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 18, 2009)
NEW YORK--Scientists from a not-for-profit foundation will test
150,000 Pfizer Inc. drug candidates as part of a search for
treatments for three tropical diseases that are spread by
insects.
Pfizer and the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2009 Category: Pharmaceuticals Source Type: news
FDA Approves New Post-Shingles Attack DrugEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From UPI Science News (November 18, 2009)
The U.S. Food and Drug Administration says it has approved a
medicated skin patch that relieves the pain associated with
shingles.
The FDA said the Qutenza
(capsaicin) 8 percent patch treats pain that occurs... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2009 Category: Pharmaceuticals Source Type: news
Pfizer Inc Submits New Pediatric Data for Lipitor to EMEAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From EquityBites (November 18, 2009)
Health care company Pfizer Inc (NYSE:PFE) declared on Wednesday the
submission of paediatric data for Lipitor (atorvastatin) to the
European Medicines Agency (EMEA).
This follows the EMEA's conclusion that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2009 Category: Pharmaceuticals Source Type: news
Vaccines on Horizon for AIDS, Alzheimer's, HerpesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 18, 2009)
MARIETTA, Pa._Malaria. Tuberculosis. Alzheimer's disease. AIDS.
Pandemic flu. Genital herpes. Urinary tract infections. Grass
allergies. Traveler's diarrhea. You name it, the pharmaceutical
industry is... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2009 Category: Pharmaceuticals Source Type: news
FDA Says Heartburn Drugs Can Interfere with PlavixEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 17, 2009)
WASHINGTON_Federal health officials said Tuesday a popular variety
of heartburn medications can interfere with the blood thinner
Plavix, a drug taken by millions of Americans to reduce risks of
heart attack... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2009 Category: Pharmaceuticals Source Type: news
FDA and Everyday Health Collaborate to Expand Reach of Consumer Health InformationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WASHINGTON & BROOKLYN, N.Y.--(BUSINESS WIRE)--Nov 17, 2009 -
The U.S. Food and Drug Administration (FDA) and
Everyday Health today announced a collaboration that will
expand the delivery of the agency's vital consumer health
information to the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2009 Category: Pharmaceuticals Source Type: news
Common Cold Virus May Have Foiled HIV Vaccine TestEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Associated Press - Nov. 16, 2009
WASHINGTON-The failure of an experimental AIDS vaccine trial two
years ago may have been caused by the common cold virus.
The vaccine was intended to block the spread of HIV, which
causes AIDS. But the test was... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2009 Category: Pharmaceuticals Source Type: news
Drug Therapy More Cost-Effective Than Angioplasty for Diabetic Patients with Heart Disease, Stanford Researcher FindsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
STANFORD, Calif.--(BUSINESS WIRE)--Nov 17, 2009 - Many patients
with diabetes should forego angioplasties for heart disease and
just take medicine instead, according to a new National Institutes
of Health study led by Stanford University School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2009 Category: Pharmaceuticals Source Type: news
Genzyme Flops at FDA: Allston Plant Problems Delay Drug Review [Boston Herald]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Boston Herald (MA) - Nov. 17, 2009
Nov. 17--The U.S. Food and Drug Administration is holding off on
its review of Lumizyme, a treatment
for the rare muscular disorder Pompe disease, until drug maker
Genzyme Corp. resolves manufacturing
problems at... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2009 Category: Pharmaceuticals Source Type: news
FDA Reviews Update to Pfizer Vaccine for KidsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Associated Press - Nov. 16, 2009
WASHINGTON-Federal health officials on Monday questioned whether
to approve an updated version of Pfizer
's best-selling anti-infection vaccine for children,
despite company studies that failed to meet certain... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2009 Category: Pharmaceuticals Source Type: news
Novartis: Lower Dose of Flu Vaccine SufficientEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Associated Press - Nov. 17, 2009
BASEL, Switzerland–Pharmaceutical maker
Novartis AG said Tuesday a U.S.
clinical study suggests that half a dose of its swine flu vaccine
may be sufficient to protect people from the virus and could... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2009 Category: Pharmaceuticals Source Type: news
FDA Says Prilosec Can Block Benefits of PlavixEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 17, 2009)
WASHINGTON–Federal health officials say a popular
heartburn medication can block the blood thinning effect of Plavix,
which is taken by millions of Americans to reduce risks of heart
attack and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2009 Category: Pharmaceuticals Source Type: news
Novartis: Lower Dose of Flu Vaccine Sufficient (AP)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Novartis: Lower Dose of Flu Vaccine
Sufficient (AP)
From Associated Press (November 17,
2009)
BASEL, Switzerland_Pharmaceutical maker Novartis AG said Tuesday
a U.S. clinical study suggests that half a dose of its swine flu
vaccine may be... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2009 Category: Pharmaceuticals Source Type: news
Merck Announces Completion of Patient Enrollment in Phase III TRA-2°P-TIMI 50 Trial of SCH 530348, a Novel, Oral Antiplatelet PAR-1 InhibitorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
More than 26,000 Patients Enrolled in Global Trial Evaluating
Investigational Antiplatelet Agent in the Long-Term Prevention of
Cardiovascular Events
Whitehouse Station, NJ, Nov. 13, 2009- Merck announced
today the completion of patient... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Drug Industry Raises Prices by 9%Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From UPI Top Stories (November 16, 2009)
U.S. drug manufacturers have been raising their prices at the
fastest clip since 1992, industry analysts say.
Wholesale prices for brand name prescription drugs have
increased by about 9 percent in the last... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Lilly's Big Cancer Bet: Seeking New BlockbustersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- While the Risks are Huge, the Rewards Could Be Giant [The
Indianapolis Star]
From Indianapolis Star (IN) (November 15, 2009)
Nov. 15--In a corner of an Eli Lilly and Co. cancer laboratory,
biologist Julie Pomeroy squeezes drops of a fluorescent... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Boehringer Ingelheim Developing 'Female Viagra'Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
German firm developing 'female Viagra' [The Day, New
London, Conn.]
From Day, The (New London, CT) (November 14, 2009)
Nov. 14--Perhaps pharmaceutical firms Pfizer Inc. and Boehringer
Ingelheim should go out on a date.
New York-based Pfizer,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
GlaxoSmithKline, Nabi to Develop Smoking VaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 16, 2009)
NEW YORK–GlaxoSmithKline PLC and Nabi Biopharmaceuticals
said Monday they will work together to develop vaccines to help
smokers give up the habit, in a deal that could be worth more than
$500... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Sanofi-Aventis Swine Flu Vaccine Cleared in FranceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 16, 2009)
PARIS–French drug maker Sanofi-Aventis SA said Monday it
has received regulatory approval in France for Panenza, its vaccine
against the swine flu virus.
Panenza, made by the company's vaccine division... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Study Raises New Questions About Merck Pill ZetiaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 16,
2009)
ORLANDO, Fla.–A new study raises fresh concerns about
Zetia and its cousin, Vytorin – drugs still taken by millions
of Americans to lower cholesterol, despite questions raised last
year about... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Particles Detected in Vials from Genzyme's Plant Not Expected to Impact Aldurazyme or NaglazymeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
NOVATO, Calif., Nov. 13 /PRNewswire-FirstCall/ -- BioMarin
Pharmaceutical Inc. (NASDAQ:BMRN) announced today that Genzyme
notified the company that, in rare circumstances, it has detected
foreign particles in some products filled at the Allston... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan (niacin extended-release)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Study results released today by the American Heart
Association and the New England Journal of Medicine
ORLANDO, Fla., Nov. 15 /PRNewswire-FirstCall/ -- Results from
the investigator-initiated ARBITER 6 - HALTS study showed patients
at high... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
FDA Sends Warning Letters for Dacogen and FosrenolEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ROCKVILLE, Md., Nov. 16,2009--The FDA has posted on its website
warning letters it sent to Eisai, Inc. for Dacogen and to Shire
Development Inc. for Fosrenol. Both letters mention misleading
information regarding the marketing of the two... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Bristol-Myers Squibb Announces Split-Off of Mead JohnsonEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Completes Major Phase in
Company's BioPharma Transformation
Provides Bristol-Myers Squibb
Shareholders an Option for a Tax-Free Exchange
Expected to be Accretive to
EPS Beginning in 2010
Reflects Strength and
Sustainability of BioPharma... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Genzyme Issues Letters to U.S. Healthcare ProvidersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 13, 2009 -
Genzyme Corp. (Nasdaq: GENZ) announced today that it has issued
letters to U.S. healthcare providers regarding its enzyme
replacement products Cerezyme® (imiglucerase for
injection),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 14, 2009 Category: Pharmaceuticals Source Type: news
Merck Strengthens Its Commitment to Advancing Cardiovascular Health CareEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Nov 14, 2009 -
Following the completion of its merger with Schering-Plough, Merck
today confirms and underscores its commitment to marketing and
developing cardiovascular medicines for a range of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 14, 2009 Category: Pharmaceuticals Source Type: news
FDA Finds Bits of Steel, Rubber in Genzyme DrugsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated
Press (November 13, 2009)
WASHINGTON-Federal health regulators have found tiny particles
of trash in drugs made by Genzyme, the second time this year the
biotechnology company has been cited for contamination issues.
The Food and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Swiss OK Novartis Swine Flu Vaccine From CellsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 13, 2009)
BASEL, Switzerland (AP)--Swiss pharmaceutical company
Novartis AG said Friday it has
received regulatory approval in Switzerland for a swine flu vaccine
produced using cell cultures instead of egg-based... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Google, Yahoo Call for Expanded Online Drug AdsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated
Press (November 12, 2009)
WASHINGTON (AP) -- Google, Yahoo and other Web companies joined
the pharmaceutical industry Thursday in urging U.S. government
regulators to make it easier to pitch drugs in online
advertisements.
The Food... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Cephalon, Barr Settle Fentora DisputeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 12, 2009)
NEW YORK (AP) -- Cephalon Inc. will give Barr Pharmaceuticals
Inc. a license to sell a generic version of the pain drug Fentora
in 2018 as part of a patent lawsuit settlement, according to a
Securities and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Google Helps You Find A Flu ShotEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From TechwebNews.com (November 12, 2009)
(TechwebNews.com ) - Google Flu Shot Finder With flu vaccines in
short supply, Google is stepping up to help people find places to
get immunized by launching a flu shot finder application for Google
Maps.
Flu... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Eli Lilly Hires Paul as Chief ResearcherEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated
Press (November 13, 2009)
NEW YORK (AP)-Lilly & Co. said Friday its science and
technology head will retire. The drug maker hired the chief
researcher at AstraZeneca PLC to replace him.
Lilly said Steven Paul will retire on Feb.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Drug Companies to Fight Neglected DiseasesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
By the UPI
Nov. 13, 2009
Officials at U.S. drug companies and non-profit organizations
say they plan to develop new drugs for "neglected" diseases.
The search for drugs to fight hard-to-treat diseases such as
malaria, tuberculosis and dengue fever... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his SuccessorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
INDIANAPOLIS, Nov. 13 /PRNewswire-FirstCall/ -- Eli Lilly and
Company (NYSE:LLY) announced today that Steven M. Paul,
M.D., executive vice president, science and technology, and
president, Lilly Research Laboratories, will retire from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
